 Local Sphingosine 1-phosphate (S1P) administration affects follicular/luteal development and enhances vascular integrity in ovarian hyperstimulation syndrome (OHSS)

DI PIETRO M; SCOTTI L; , PASCUALI N; BAS D; IRUSTA G; TESONE M; ABRAMOVICH D; PARBORELL F

Chascomús

Congreso; LIX Reunión Científica Anual de la Sociedad Argentina de Biología; 2014

OHSS remains the most serious complication of gonadotropin treatment. The main clinical components are marked enlargement of the ovaries, with luteal and hemorrhagic cysts, and an excessive fluid shift. S1P is a lysophospholipid that acts to promote endothelial cell barrier function. Previously, we observed decreased S1P levels in ovarian follicular fluid (FF) from OHSS patients. The aim of this study was to investigate the effects of S1P administration on the follicular and luteal development, cystic structures, peri-endothelial cell area, S1P1/3 receptors, sphingosine lyase (Sly)and kinase (Sk), N-cadherin, nectin-2 and occludin levels in ovaries from an OHSS rat model. Sprague Dawley rats were injected with eCG (10 IU) followed by hCG (10 IU) (Control). The OHSS group was injected with eCG (50 IU / day) for 4 consecutive days and 24 hours later with hCG (25 IU). The group OHSS + S1P received S1P (5ul/ovary; 1mM) under the bursa of one ovary in the day of hCG inyection. The rats were sacrificed 48h post hCG. Ovaries were isolated for histological sections to detect α-actin (cell periendothelial marker) by IHQ and to isolate proteins by western blot. S1P decreased significantly the percentage of corpora lutea and cyst structures compared to OHSS group alone (p